No Routine Coagulation Testing Needed in Asymptomatic Patients
In asymptomatic patients without personal or family bleeding history and not on anticoagulants, PT and aPTT should not be ordered at all—instead, obtain a structured bleeding assessment tool (BAT) score and complete blood count (CBC) with platelet count only if clinically indicated.
The Evidence Against Routine Screening
PT and aPTT have no predictive value for bleeding risk in asymptomatic patients 1, 2. These tests were designed to monitor anticoagulation and detect specific factor deficiencies, not to screen for bleeding risk in patients without clinical suspicion 3. The most efficient method for predicting bleeding is clinical history, not laboratory tests 1.
What Should Be Done Instead
Primary Assessment
Structured bleeding history using a validated BAT score 4
- This objectively documents bleeding symptoms
- Nearly all clinicians (98%) include family history assessment 4
Complete blood count (CBC) with platelet count 5
- Only if there are any clinical concerns
- Identifies thrombocytopenia if present
- 65% of specialists perform this as first-line when evaluating bleeding 4
Additional Considerations When Clinically Indicated
If the bleeding assessment tool reveals concerning symptoms, then consider:
Ferritin level 4
- Persistent iron deficiency may suggest occult bleeding phenotype
- Performed by 69% of specialists in bleeding disorder workups 4
Medication review 4
- Exclude aspirin and NSAID use (affects platelet function)
- 88% of clinicians assess this when evaluating bleeding disorders 4
Beighton score for hypermobility 4
- Associated with bleeding symptoms
- Simple physical examination
- Only 55% of clinicians currently assess this despite its relevance 4
Critical Pitfalls to Avoid
Do not order PT/aPTT "just because" surgery is planned. Most surgical bleeding is due to surgical technique, not coagulopathy, and therefore cannot be predicted by these tests 1. The tests lack both sensitivity and specificity for bleeding risk in asymptomatic individuals 2.
PFA-100 and bleeding time are also not recommended for screening asymptomatic patients due to insufficient specificity and sensitivity 6.
When Coagulation Testing IS Appropriate
Coagulation testing becomes appropriate only when:
- Positive bleeding history is documented by BAT score 4
- Family history of bleeding disorders is present 4
- Patient is on anticoagulants requiring monitoring 3
- Specific clinical findings suggest hemostatic abnormality 5
In these scenarios, the testing panel should include aPTT, PT, Clauss fibrinogen, von Willebrand factor antigen and activity, and coagulation factors VIII, IX, and XI 4.